Home > Online Clinic News > Cialis Gets Go-Ahead for Prostate Treatment

Latest News

by Robert MacKay, Sunday, October 16, 2011 | Categories: Cialis

The Food and Drug Administration have announced that it has given Eli Lily’s successful erectile dysfunction drug, Cialis, the go ahead for the treating of enlarged prostate, benign prostatic hyperplasia, BPH, and with men who suffer from erectile dysfunction, they will experience double the benefit from this treatment.

Phase III trials revealed that the 5mg, once daily consumption of tadalafil (Cialis’ active ingredient) improved symptoms associated with both conditions significantly.

BPH causes men to experience sudden urges to pass urine and more frequently during the night. There are a few treatments on the market for BPH however none have been approved to treat both conditions simultaneously.

Cialis was already hot on the heels of Viagra and set to become the most popular of the erectile dysfunction treatments and now with the FDA’s approval for its alternative use, the bar has been raised even higher.





 
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close